Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Stabilized brain volumes seen in phenserine-treated Alzheimer's patients

April 25, 2006

Recent patents cover therapeutic agents for neurological disorders

April 24, 2006

ACP-103 increases slow wave sleep in clinical study

April 24, 2006

Leuprolide beneficial in phase II Alzheimer's disease study

April 24, 2006

New gamma-secretase inhibitor markedly reduces Abeta levels in vivo

April 20, 2006

Fast track designation for TheraQuest's Tramadol ER

April 20, 2006

Cortex receives written confirmation on CX-717 clinical hold

April 20, 2006

Athenagen acquires Osprey Pharmaceutical

April 20, 2006

Evaluation of Coenzyme Q10 in Duchenne muscular dystrophy moves to phase III

April 20, 2006

New therapeutic agents for psychological disorders disclosed

April 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...